Quality of Earnings vs Normalized EBITDA in M&A Valuation

Quality of Earnings and normalized EBITDA answer different transaction questions

In middle-market M&A, sellers often focus on the multiple while buyers focus first on the earnings base to which the multiple will be applied. That difference in emphasis explains many late-stage valuation disputes. Management may present adjusted EBITDA with a series of add-backs. The buyer may initially accept the concept, sign a letter of intent using a provisional earnings figure, and then commission a Quality of Earnings review. If the evidence does not support the bridge, the buyer may reduce accepted EBITDA, change the multiple, reduce leverage, or revise the structure.

The distinction between Quality of Earnings and normalized EBITDA is therefore not academic. Normalized EBITDA is an estimate of sustainable operating earnings after adjustments for unusual, non-recurring, non-operating, or owner-specific items. Quality of Earnings is a broader diligence process that evaluates whether the company’s accounting records, revenue patterns, margins, expenses, add-backs, working capital, and cash conversion support that estimate.

A buyer can accept that an expense was unusual and still decline to give full valuation credit if the business needs a replacement cost after closing. A buyer can also agree that historical EBITDA is accurate while concluding that the earnings are low quality because revenue is concentrated, margins are volatile, collections are weak, or capital requirements are understated. This is why the phrase EBITDA quality is useful: it describes the reliability and economic durability of the earnings, not merely the mathematical accuracy of the EBITDA calculation.

Owners evaluating a sale should understand the entire sequence. Reported EBITDA is the accounting starting point. Management-adjusted EBITDA is the seller’s proposed bridge. Normalized EBITDA is the more supportable estimate of sustainable earnings. QoE is the review that tests the bridge. Buyer-accepted EBITDA is the amount ultimately used in underwriting. The valuation multiple buyers use is then applied to that accepted base, subject to buyer-specific risk and market conditions.

Executive summary

Normalized EBITDA answers a measurement question: what earnings level best represents the company under normal ownership and operating conditions? Quality of Earnings answers a validation question: do the accounting records, operating trends, and cash-flow evidence support that earnings claim? A strong transaction requires both a defensible measure and a credible review process.

The most common source of disagreement is not the definition of EBITDA. It is whether a proposed adjustment should receive full, partial, or no credit. Owner compensation, personal expenses, one-time legal fees, temporary duplicate costs, discontinued activities, run-rate changes, and unusual revenue items can all affect the bridge. The complete classification and calculation belongs in the dedicated adjusted-versus-normalized EBITDA guide. This article explains how QoE tests the result.

QoE can affect valuation in several ways. It can change the earnings base, reduce or increase confidence in the multiple, influence lender leverage, change working-capital assumptions, identify debt-like items, and alter the buyer’s willingness to close on the original letter-of-intent terms. The seller’s objective should not be the largest possible adjusted EBITDA figure. It should be the strongest supportable earnings case that remains consistent from marketing materials through the purchase agreement and funds flow.

A well-prepared owner should be able to explain the bridge from reported EBITDA to management-adjusted EBITDA, identify which adjustments are historical versus pro forma, show the source support, reconcile the result to monthly financials, and explain how the earnings convert into cash. When that preparation is complete before buyer outreach, the seller is less likely to negotiate valuation from a defensive position after exclusivity.

Key takeaways

• Normalized EBITDA is an adjusted earnings measure; QoE is the financial-diligence process used to test the measure.
• Reported EBITDA, management-adjusted EBITDA, normalized EBITDA, and buyer-accepted EBITDA may all differ in the same transaction.
• Quality of Earnings adjustments can move EBITDA upward or downward and may also affect the buyer’s confidence in the valuation multiple.
• EBITDA quality depends on revenue durability, margin repeatability, expense completeness, working capital, cash conversion, and the absence of unsupported adjustments.
• A clean audit does not eliminate the need for QoE because the two reviews answer different questions.
• The seller’s strongest objective is a consistent, documented earnings bridge that survives diligence and remains aligned with purchase-price mechanics.

The one-minute QoE and normalized EBITDA map

The sequence is easiest to understand as a set of decisions. The accounting records establish reported EBITDA. Management identifies possible normalizations. The transaction team categorizes and documents those items. QoE tests whether the bridge is accurate, recurring, properly classified, and consistent with cash flow. The buyer then determines the EBITDA it is willing to underwrite. Only after that step does the discussion move fully to the multiple, financing, and final purchase-price mechanics described in how buyers build a valuation model.

Each stage can change the answer. An owner-compensation adjustment may be valid but reduced for replacement cost. A one-time expense may be accepted, while a claimed run-rate saving receives no credit because implementation is incomplete. A revenue timing issue may reduce EBITDA even though it was not included in the seller’s add-back schedule. A working-capital anomaly may not reduce EBITDA but may still lower proceeds through the closing adjustment.

This is why the direct comparison matters. Normalized EBITDA cannot be evaluated without the diligence record, and a QoE report is not meaningful unless its findings are connected to the earnings base used in valuation.

Quality of Earnings vs. normalized EBITDA: direct comparison

Quality of Earnings and normalized EBITDA are linked, but they differ in purpose, scope, timing, and output. The comparison below keeps the distinction precise without turning either concept into a substitute for the other.

The clearest way to remember the difference is that normalized EBITDA is a conclusion about earnings, while QoE is the process that tests the evidence behind the conclusion. The two should reconcile, but they are not interchangeable.

What normalized EBITDA means in plain English

Normalized EBITDA meaning can be stated simply: it is the earnings level the business is expected to produce under ordinary ownership and operating conditions after distortions are removed. Those distortions may include one-time costs, non-operating income, owner-specific compensation, personal expenses, unusual professional fees, temporary duplicate costs, or other items that do not represent the ongoing business.

The word normalized does not mean automatically increased. A proper normalization can move EBITDA upward or downward. If the owner is paid above market for a role, EBITDA may increase after market replacement compensation is considered. If the owner is underpaid while performing several functions, normalized EBITDA may decrease because the buyer must add a realistic replacement cost. Non-recurring income, temporary grants, isolated project gains, or unusually favorable timing may also require downward adjustments.

In British and Commonwealth usage, the same concept may be written as normalised EBITDA or EBITDA normalisation. The spelling changes, but the transaction meaning does not. Both refer to a more representative earnings base after the financial period is adjusted for items that distort maintainable performance.

The direct comparison with QoE is important because normalized EBITDA remains a proposed earnings conclusion until the evidence is tested. A seller can prepare a disciplined normalization schedule before market, but buyers will still ask whether the adjustments reconcile to the books, whether the costs truly disappear, whether revenue and margins support the run rate, and whether the bridge is consistent with working capital and cash flow.

That plain-English meaning provides the foundation for comparing the concepts. The complete formula, step-by-step calculation, owner-compensation treatment, related-party adjustments, and run-rate rules are covered in Normalized EBITDA in M&A: Definition, Formula, Adjustments & QoE.

Reported EBITDA, adjusted EBITDA, normalized EBITDA, and buyer-accepted EBITDA

Readers comparing EBITDA vs normalized EBITDA, normalized EBITDA vs EBITDA, reported vs adjusted EBITDA, and management EBITDA are usually trying to understand where each earnings figure sits in the transaction sequence. The labels matter because each figure represents a different level of adjustment and buyer acceptance.

The ladder does not always move in one direction. Management-adjusted EBITDA may be higher than reported EBITDA because of add-backs. QoE may accept some items, reject others, and identify additional downward or upward adjustments. Buyer-accepted EBITDA may differ again because the buyer applies replacement-cost assumptions, risk tolerances, financing constraints, or a different view of the measurement period.

The detailed calculation and terminology belong in Normalized EBITDA vs. Adjusted EBITDA and Normalized EBITDA in M&A. This page focuses on what happens when the proposed earnings figure enters the QoE process.

Why QoE findings and normalized EBITDA can diverge

QoE and normalized EBITDA can diverge because they are built from different levels of information and judgment. Management may prepare normalized EBITDA from its understanding of the business, while the QoE provider works from detailed accounting records, monthly trends, customer data, invoices, payroll, contracts, working-capital schedules, and other evidence. The provider may also apply different materiality thresholds or accounting classifications.

The difference is not always an accusation that management is wrong. A seller may reasonably believe an expense is non-recurring, while the buyer concludes that a replacement cost remains. A recent price increase may be real, but the QoE provider may give only partial credit because the new pricing has not been collected across enough months. A customer loss may occur after the seller prepared the bridge, requiring the buyer to update the earnings period. The conclusion changes because the evidence and timing changed.

Divergence also arises when management combines historical normalization, implemented run-rate effects, and future improvements in one number. QoE typically tries to separate those categories. Historical normalization may support current value. Implemented changes may receive partial or full credit if the benefit is visible. Prospective improvements may belong in a forecast or buyer upside case rather than the purchase-price EBITDA.

Another source of divergence is scope. A QoE provider may identify a working-capital or debt-like issue that does not change EBITDA but still affects transaction economics. Management may view the EBITDA as fully validated, while the buyer views the overall earnings quality as weaker because cash conversion, collections, deferred revenue, or required capital is less favorable than expected.

The useful question is therefore not which party has the “right” label. It is which conclusion is best supported and how the difference should flow through valuation, financing, working capital, and structure. A disciplined process makes those bridges explicit rather than allowing every concern to become a generalized price reduction.

Quality of Earnings adjustments versus EBITDA normalization adjustments

Quality of Earnings adjustments are findings that change or clarify the earnings bridge during diligence. They are not limited to the seller’s positive add-backs. A QoE review may validate an add-back, reduce it, reject it, identify an omitted recurring expense, correct a revenue cut-off issue, reclassify an item, or highlight a working-capital effect that belongs outside EBITDA and within the working-capital peg analysis.

An EBITDA normalization adjustment begins with the question of whether historical earnings contain an unusual, non-recurring, owner-specific, non-operating, or classification-related distortion. A QoE adjustment reflects what the diligence evidence supports after the records are tested. The same line item can therefore have a management amount, a QoE amount, and a buyer-accepted amount.

For the detailed QoE procedures and common flags, see Quality of Earnings: What Buyers Flag. The important point here is that QoE can change both the amount and the interpretation of normalized EBITDA.

Why EBITDA adjustments become controversial during QoE

EBITDA adjustments become controversial during Quality of Earnings because each accepted adjustment can be multiplied into enterprise value. At a 7.0x multiple, a $500,000 adjustment can represent $3.5 million of implied value before debt, working capital, and structure. The seller therefore has an incentive to identify every supportable adjustment, while the buyer has an incentive to test whether the cost truly disappears or the benefit truly continues.

The controversy is rarely about whether adjustments are allowed. Add-backs and normalizations are standard in private-company M&A. The disagreement concerns classification, recurrence, evidence, replacement cost, timing, and double counting. A one-time legal matter may be straightforward if the dispute is resolved and documented. Recurring legal fees described as unusual are different. A founder-compensation adjustment may be valid, but only after the buyer accounts for the duties that must be replaced.

Disputes also arise when an adjustment depends on future execution. A completed facility closure with visible cost savings can be different from a planned closure that still requires severance, relocation, and operational changes. A signed price increase that customers are already paying can be different from a proposed increase management hopes to implement. Buyers generally resist paying the seller full value for benefits the buyer must create after closing.

Credibility matters. A seller who presents a balanced bridge, includes downward adjustments, excludes weak items, and ties each line to source documents can strengthen the overall earnings case. A seller who describes recurring costs as non-recurring, changes explanations, or mixes buyer synergies into normalized EBITDA can cause buyers to question the entire schedule.

For a full treatment of common add-backs, owner compensation, personal expenses, related-party costs, pro forma items, and buyer challenges, see Normalized EBITDA vs. Adjusted EBITDA.

What EBITDA quality means in a transaction

EBITDA quality refers to how reliable, repeatable, transferable, and cash-generative the earnings appear after a buyer reviews the company. The phrase is less formal than Quality of Earnings, but it captures the economic question behind the diligence: does the EBITDA represent durable operating performance, or does it depend on timing, concentration, aggressive accounting, underinvestment, or adjustments that will not continue?

High-quality EBITDA is generally supported by consistent accounting, recurring or repeatable revenue, stable gross margin, complete expense recognition, limited dependence on one customer or founder, reasonable working-capital requirements, and a clear conversion of earnings into cash. That broader distinction is also why buyers focus on cash flow rather than accounting profit. Lower-quality EBITDA may still be correctly calculated, but the buyer can view it as fragile because the underlying business conditions are less dependable.

This distinction explains why a QoE report can leave the reported EBITDA nearly unchanged while the valuation still weakens. The buyer may conclude that the number is accurate but risky. That risk can appear through a lower multiple, less leverage, a larger escrow, more contingent consideration, or a more conservative working-capital position. The separate guide on what increases EBITDA multiples explains how revenue durability, management depth, margin quality, and lower buyer-perceived risk affect the multiple itself.

Management EBITDA versus buyer-underwritten EBITDA

Management EBITDA is usually built to explain how the company performed after identifiable adjustments. Buyer-underwritten EBITDA is built to answer a different question: what earnings can the buyer rely on after closing and defend to lenders, an investment committee, or internal management? The two figures may match, but buyers do not assume they will.

A seller can improve credibility by separating three categories. Historical normalization items address distortions already reflected in the financial statements. Implemented run-rate items address changes already completed but not fully visible in the trailing period. Prospective improvements address actions that may happen later. Buyers are most likely to capitalize supportable historical adjustments, may give partial credit to implemented run-rate changes, and often reserve future improvements for their own upside case.

Private equity buyers may build a lender case, investment-committee case, base case, upside case, and downside case. A strategic acquirer may separately model synergies. Those buyer-created assumptions can support interest without increasing the seller’s purchase-price EBITDA. How private equity prices deals in practice provides the deeper sponsor-underwriting context.

This is also why a seller should not describe a buyer’s synergy as a normalization adjustment. The business should receive credit for earnings and improvements it can support before closing. Buyer-created benefits may influence competition, but they do not automatically belong in the seller’s normalized EBITDA bridge.

How TTM, LTM, run-rate, and LQA EBITDA affect the comparison

QoE and normalized EBITDA also depend on the measurement period. TTM EBITDA and LTM EBITDA generally refer to the trailing or last twelve months. Run-rate EBITDA estimates earnings based on current conditions that may not be fully reflected in the trailing period. LQA EBITDA, or latest-quarter annualized EBITDA, multiplies a recent quarter to create an annualized figure.

These measures can produce different answers even before specific add-backs are considered. A fast-growing company may show a higher run-rate or latest-quarter annualized figure than its trailing EBITDA. A seasonal company can be distorted if one quarter is annualized. A company that recently lost a customer may show trailing EBITDA that overstates current performance. The buyer uses QoE to understand the period, timing, seasonality, and evidence behind the selected earnings base.

The direct comparison remains the same: the earnings measure is the proposed input, and QoE tests whether that input is representative. A seller should not switch from TTM to run-rate or LQA solely because the alternative produces a higher number. The period should match the operating reality, transaction timing, and evidence available to the buyer and lenders.

For the full treatment of trailing performance, use TTM EBITDA in M&A. For implemented changes and forward-looking adjustments, use Run-Rate EBITDA in M&A. Here, the measurement-period discussion is limited to its effect on the QoE-versus-normalized-EBITDA comparison.

How revenue, margins, working capital, and cash conversion affect the conclusion

QoE evaluates more than the add-back schedule because the quality of normalized EBITDA depends on the business activity beneath it. Revenue recognition, customer durability, gross margin, payroll, accruals, reserves, working capital, and cash conversion can all change whether the earnings are considered sustainable.

Revenue quality asks whether sales are recorded in the proper period, supported by contracts or customer activity, collectible, repeatable, and free from unusual pull-forward. Margin quality asks whether gross profit is stable, whether cost allocations are complete, and whether recent margin improvement reflects structural progress or temporary conditions. Expense completeness asks whether the historical period includes the people, systems, maintenance, compliance, and overhead required to sustain revenue after closing.

Working capital and cash conversion provide a separate but connected test. EBITDA can look attractive while receivables age, inventory builds, deferred revenue creates future obligations, or capital expenditures consume cash. Those issues may not always change EBITDA directly, but they can affect leverage, purchase-price adjustments, and the buyer’s confidence in the earnings. The EBITDA-to-free-cash-flow bridge addresses the cash-conversion analysis, while revenue peg versus working-capital peg explains why different transaction adjustments should not be confused.

Owners seeking a complete review of revenue, margins, cash conversion, working capital, and common flags should use the detailed QoE diligence guide.

Quality of Earnings and earnings management

Quality of Earnings and earnings management are related but different concepts. Earnings management generally refers to choices or actions that influence reported results, sometimes within accounting rules and sometimes more aggressively, to achieve a desired presentation. QoE evaluates whether accounting choices, timing, estimates, reserves, classifications, and operating decisions make the reported earnings less representative of sustainable performance.

Not every normalization adjustment reflects earnings management. Founder-led companies commonly have owner-specific compensation, personal expenses, one-time professional fees, related-party arrangements, or unusual events that create legitimate adjustments. The presence of add-backs is not itself a red flag. The concern arises when revenue is accelerated, expenses are deferred, reserves are understated, costs are reclassified, or recurring items are repeatedly described as non-recurring.

QoE providers examine patterns rather than labels. They may compare monthly cutoffs, cash collections, customer contracts, gross margins, payroll, reserves, vendor expenses, and subsequent periods to determine whether the earnings presentation is balanced. A company that voluntarily identifies non-recurring benefits and downward adjustments can strengthen credibility because normalization should work in both directions.

For sellers, the practical lesson is to avoid treating QoE as a contest over the highest possible EBITDA. The objective is to present the most supportable view of sustainable earnings and explain any accounting judgments before buyers interpret them as hidden risk. The detailed procedures used to identify reporting and accounting concerns are covered in Quality of Earnings: What Buyers Flag.

Quality of Earnings versus an audit, review, or compilation

An audit, review, compilation, and QoE engagement can examine some of the same financial records, but they serve different purposes. An audit provides assurance on whether financial statements are fairly presented under the applicable accounting framework. A review provides limited assurance. A compilation presents financial information without assurance. QoE is transaction-focused analysis designed to help a buyer or seller understand sustainable earnings, normalized EBITDA, working capital, and other deal-relevant financial issues.

A company can have audited financial statements and still need QoE. The audit may support confidence in the historical statements, while the QoE asks questions that are more specific to purchase-price underwriting: which earnings are recurring, which add-backs are supportable, whether recent margins are representative, whether customer and revenue patterns create risk, and whether working capital and cash conversion support the transaction model.

QoE is also not an independent valuation opinion. It informs the financial inputs used in valuation. A buyer still must select the valuation method, multiple, financing, and deal structure. Owners should therefore treat QoE, company-specific valuation analysis, and purchase-price mechanics as connected but distinct workstreams.

Seller-side QoE versus buyer-side QoE

A seller-side QoE and a buyer-side QoE may review similar records, but they are commissioned at different points and for different purposes. A seller-side review is intended to identify issues early, organize the earnings bridge, improve consistency, and prepare management for buyer diligence. A buyer-side review is intended to support the buyer’s underwriting, financing, and risk decisions.

The seller-side report does not eliminate buyer diligence or guarantee that buyers will accept the findings. It can, however, reduce avoidable surprises by giving the seller time to reconcile financials, support add-backs, explain monthly volatility, separate EBITDA issues from working-capital or debt-like items, and correct errors before buyers gain exclusivity.

A buyer-side provider may use different materiality thresholds, assumptions, periods, or classifications. The buyer may also apply conclusions that go beyond the report because valuation depends on strategy, leverage, risk tolerance, and integration plans. The seller’s preparation should therefore focus on evidence and consistency rather than assuming one report will control every later conclusion.

In a competitive process, early preparation can help the seller compare how different buyers interpret the same earnings record. A structured M&A auction process and credible buyer alternatives may preserve leverage when one buyer takes an unusually conservative position, although competition cannot cure a genuinely weak earnings case. A competitive sale process can protect leverage only when the financial story is credible.

Worked example: how QoE changes normalized EBITDA and value

Assume a founder-led company reports $5.0 million of trailing-twelve-month EBITDA. Management proposes $1.0 million of positive adjustments: $300,000 of excess owner compensation, $250,000 of transaction and one-time professional fees, $200,000 of temporary duplicate costs, $150,000 of an implemented price increase, and $100,000 of anticipated cost savings. Management-adjusted EBITDA is therefore $6.0 million.

During QoE, the provider verifies the transaction expenses, accepts part of the owner-compensation adjustment after replacement cost, confirms that the duplicate costs have rolled off, gives partial credit to the price increase, and rejects the anticipated savings because implementation is incomplete. The provider also identifies $100,000 of recurring professional support that management omitted. The resulting QoE-adjusted EBITDA is $5.5 million.

At an 8.0x multiple, the difference between $6.0 million and $5.5 million of EBITDA equals $4.0 million of enterprise value. If the findings also reduce the buyer’s confidence in the multiple, the impact can be larger. If the QoE instead validates the bridge and resolves uncertainty, it can protect the original value and reduce pressure for earnouts, escrows, or other structure.

The example illustrates why owners should understand why an LOI is not final value. The buyer may sign the LOI using management EBITDA and reserve the right to confirm the earnings base during diligence. The final transaction depends on the number that survives review and the terms used to allocate any remaining uncertainty.

How the comparison affects valuation, financing, and proceeds

Quality of Earnings can affect valuation through the earnings base, the multiple, financing, and transaction terms. The most visible effect is a change in buyer-accepted EBITDA. Because enterprise value is often calculated as accepted EBITDA multiplied by a valuation multiple, even a modest adjustment can create a material price difference.

The second effect is confidence in the multiple. A buyer may accept the numerical bridge but still conclude that customer concentration, revenue volatility, weak margin visibility, or poor cash conversion makes the earnings riskier. That conclusion can reduce the multiple even when EBITDA remains unchanged. Conversely, a clean and well-supported earnings profile may support stronger buyer confidence, although QoE itself does not create a market premium.

The third effect is financing. Lenders may use a more conservative EBITDA figure than the buyer’s internal model. If lender credit is lower, the buyer may need more equity, reduce price, request seller financing, increase rollover equity, or change the structure. Sources and uses in M&A explains how debt, equity, rollover, seller notes, and transaction fees fit together.

The fourth effect is the bridge from enterprise value to proceeds. QoE findings may identify working-capital patterns, debt-like obligations, deferred revenue, accrued costs, or unpaid transaction expenses that affect cash at closing. Owners should connect the earnings analysis with purchase-price adjustments, debt-like items, and the seller-proceeds bridge rather than treating each schedule independently.

How normalized EBITDA is used in business valuation

Normalized EBITDA in business valuation is usually the earnings denominator used when a buyer applies an EBITDA multiple. The basic expression is simple: buyer-accepted EBITDA multiplied by the supportable valuation multiple equals enterprise value. The difficult part is determining which EBITDA and which multiple are justified.

QoE informs the first input. It can validate the seller’s earnings bridge, reduce or reject adjustments, identify omitted costs, correct timing, and clarify the quality of revenue and margins. The buyer then considers scale, growth, customer concentration, management depth, sector conditions, buyer synergies, leverage, and other factors when selecting the multiple. A clean QoE can support confidence in the inputs, but it does not by itself determine the multiple or the value.

This distinction prevents a common mistake. Owners sometimes assume that a favorable QoE conclusion guarantees a premium valuation. QoE can preserve an earnings base and reduce uncertainty, but the company still may have concentration, limited growth, founder dependence, weak market positioning, or other risks that affect the multiple. Conversely, a strategically attractive company may command strong buyer interest but lose value if the earnings bridge does not withstand diligence.

The accepted EBITDA also affects financing. Lenders may use a lower number than the buyer’s internal model, especially when adjustments are pro forma or the cash conversion is weak. Lower lender credit can require more buyer equity, more rollover, seller financing, or a lower price. The valuation and financing conclusions should therefore reconcile rather than being discussed as separate narratives.

Owners asking how much their business is worth should understand that calculator and multiple estimates remain directional until the earnings base is defined. EBITDA Multiples Calculator Explained and Do Buyers Use EBITDA Multiples? provide the deeper valuation-method context.

Why the earnings gap often appears after the LOI

Many letters of intent are signed before the buyer completes a full QoE review. The buyer may rely on management financials, preliminary add-back schedules, limited customer detail, and a provisional view of working capital. That allows the parties to agree on headline terms, but the terms often remain subject to confirmatory diligence.

After exclusivity, the buyer’s leverage usually improves because the seller has stepped away from other bidders. If QoE then identifies a material earnings gap, the buyer may seek a price reduction, a lower multiple, more contingent consideration, a larger escrow, revised working-capital terms, or a broader indemnity package. Owners should compare those changes using a full offer-comparison framework, not headline price alone. Some findings justify a change. Others become negotiation positions. The seller’s ability to distinguish between the two depends on preparation, evidence, and remaining alternatives.

A disciplined seller should therefore test the earnings bridge before signing an LOI. That does not mean every issue must be resolved, but management should know where the buyer is likely to challenge the case, how much valuation exposure exists, and whether the issue belongs in EBITDA, working capital, debt-like items, or structure. The article on why deals lose value during diligence addresses the broader re-trade dynamic.

Avoiding double counting across EBITDA and purchase-price adjustments

One of the most important transaction disciplines is preventing the same economic issue from being counted more than once. An item can appear in EBITDA, working capital, debt-like items, deferred revenue, or the purchase-price adjustment, but the schedules must reconcile so the buyer does not receive duplicate value.

For example, an unpaid transaction expense may be added back to EBITDA because it is non-recurring, but the unpaid liability may still reduce seller proceeds at closing. That is not necessarily double counting because one treatment affects the earnings base and the other settles a liability. By contrast, a recurring operating accrual should not reduce EBITDA, reduce the working-capital peg, and be deducted again as debt-like without a clear economic basis.

Deferred revenue creates similar complexity. The accounting treatment can affect recognized revenue and normalized EBITDA, while the remaining service obligation may influence working capital or debt-like treatment. The correct classification depends on the contract economics and purchase agreement, not a generic label.

A strong transaction model reconciles the QoE findings with the normalized EBITDA bridge, working-capital schedule, net-debt and debt-like schedule, purchase-price adjustment, and funds flow. This is one reason owners should evaluate revenue and working-capital peg concepts carefully rather than applying overlapping adjustments without a complete bridge.

What sellers should prepare before QoE begins

Seller preparation should be proportionate to the transaction, but the core comparison requires a clear record of how management moved from reported EBITDA to its proposed normalized amount. Each material adjustment should identify the account, period, amount, rationale, supporting document, recurrence assessment, and expected post-closing treatment.

The seller should also reconcile the bridge to the monthly financial statements, general ledger, tax returns or audited statements where applicable, and the management reporting used in buyer materials. Differences should be explained before buyers identify them. A consistent bridge is more persuasive than a larger number that changes as diligence progresses.

Management should know which items are historical normalization, which are implemented run-rate changes, and which are prospective improvements. It should also understand the downside case. A seller who can explain why a weaker adjustment was excluded often appears more credible than a seller who includes every conceivable add-back.

For a complete preparation checklist, see the QoE report and red-flags guide. The immediate priority is preparing the bridge and evidence needed to explain the difference between normalized EBITDA and the QoE conclusion. Owners evaluating broader readiness should also use what gets a business ready for sale and the Sell-Side Readiness Assessment.

What buyers focus on when they compare QoE with normalized EBITDA

Buyers focus on the points where the seller’s earnings claim depends on judgment. They test whether expenses described as non-recurring appear in prior periods, whether cost reductions are complete, whether owner roles require replacement, whether revenue belongs in the selected period, whether customer concentration threatens the forecast, and whether cash conversion supports the EBITDA.

They also look for consistency across the process. The EBITDA in the confidential information memorandum should reconcile to the data room, QoE schedules, lender materials, management presentation, purchase agreement, and funds flow. When definitions change, buyers may conclude that management lacks control over the numbers or is adjusting the story to preserve price.

Sophisticated buyers do not necessarily reject a business because it has complex adjustments. They become concerned when the adjustments are poorly supported, one-sided, duplicated, or inconsistent with operating reality. A clear explanation of a temporary issue can preserve confidence. An unexplained issue discovered late can affect both price and closing certainty. How buyers identify hidden risk during diligence explains how isolated questions can become broader underwriting concerns.

Owners should also understand that buyers evaluate the transaction team. Clear financial materials, disciplined responses, and consistent negotiation can support credibility. How buyers evaluate M&A advisors explains why process quality can influence how seriously buyers treat the seller’s case.

How an M&A advisor connects QoE findings with valuation and deal terms

An M&A advisor does not replace the accounting firm that performs QoE, but the advisor should connect the findings to valuation, buyer communications, process leverage, and transaction terms. Before outreach, the advisor can help management frame the earnings bridge, distinguish stronger adjustments from weaker items, and understand how buyers may use the conclusions.

During diligence, the advisor should help prevent a narrow accounting issue from becoming an unsupported broad valuation claim. That includes comparing buyer positions, reconciling the effect of findings on enterprise value and proceeds, and keeping the financial schedules aligned with the LOI and purchase agreement. A senior-led sell-side advisory engagement should remain involved through working-capital, debt-like, escrow, earnout, and funds-flow negotiations.

The advisor also has to exercise judgment before accepting a mandate. If the seller insists on unsupported adjustments, refuses to prepare the records, or expects buyers to ignore material issues, the process may not be ready. Why good M&A advisors say no explains why disciplined representation sometimes requires declining an engagement until the business and expectations are better prepared.

Owners who need a preliminary value frame can begin with the Business Valuation Calculator, but calculator output should be interpreted carefully. How buyers interpret valuation calculators explains why the accepted earnings base, not the entered number alone, determines whether a directional estimate survives transaction diligence.

Frequently asked questions

Related Auxo resources for earnings quality, valuation, and transaction execution

The direct comparison between QoE and normalized EBITDA is one part of a broader transaction framework. Owners also need to understand valuation, seller preparation, buyer process, working capital, debt-like items, and the final proceeds bridge.

Advisory, valuation, and readiness

• Mergers & Acquisitions Advisory Services — Auxo’s broader advisory hub for business sales, acquisitions, recapitalizations, and transaction execution.
• Sell-Side M&A Advisory — Senior-led preparation, buyer outreach, bid comparison, diligence, negotiation, and closing support.
• Valuation Services — Company-specific valuation analysis for owners evaluating a sale, recapitalization, or strategic alternative.
• Market Value Study — A structured assessment of buyer appetite, likely valuation, positioning, and transaction readiness.
• Business Valuation Calculator — A directional tool for testing how earnings and multiples affect implied enterprise value.
• Sell-Side Readiness Assessment — Helps owners identify financial, operational, and management gaps before buyer diligence.

Process and valuation context

• Sell-Side M&A Process — Shows where preparation, buyer outreach, LOI negotiation, QoE, and closing fit in the process.
• Business Valuation Methods — Explains the income, market, and transaction approaches used to frame private-company value.

Closing economics and purchase-price mechanics

• Enterprise Value to Seller Proceeds — Connects the accepted earnings base with net debt, working capital, fees, and final seller economics.
• Purchase Price Adjustment in M&A — Explains how closing balance-sheet mechanics can increase or reduce proceeds.
• Working Capital Peg in M&A — Shows how buyers set the normal working-capital target delivered at closing.
• Debt-Like Items in M&A — Explains liabilities and obligations that may be deducted from enterprise value.

Together, these resources connect normalized earnings and QoE findings with the broader questions owners face in a transaction: what the business is worth, how buyers will test the financial story, how the process should be managed, and how headline enterprise value becomes the amount ultimately received.

Media & press inquiries

Auxo Capital Advisors welcomes inquiries from journalists, editors, podcast producers, and event organizers covering middle-market M&A, Quality of Earnings, normalized EBITDA, valuation, buyer underwriting, working capital, and transaction mechanics.

For media requests related to this article, please email info@auxocapitaladvisors.com.

About the author

George Barsom is Founder & Managing Director of Auxo Capital Advisors. He advises founder-led and middle-market businesses on valuation, sell-side preparation, transaction positioning, and M&A execution.

His work focuses on translating operating performance into buyer-relevant underwriting narratives so owners can approach a sale, recapitalization, or capital process with clearer expectations around value, structure, and diligence risk. Auxo’s core practice areas include Mergers & Acquisitions Advisory Services, Capital Advisory Services, and Valuation Services.

Disclosure

This article is provided for general informational and educational purposes only. It reflects a transaction-advisory perspective on Quality of Earnings, normalized EBITDA, adjusted earnings, financial diligence, buyer underwriting, seller proceeds, and related middle-market M&A structures. It is not legal, tax, accounting, investment, securities, valuation, regulatory, or other professional advice and should not be relied on as a substitute for transaction-specific guidance.

Any examples, adjustments, scenarios, formulas, operating metrics, or valuation references are simplified for explanatory purposes. Actual outcomes depend on company-specific facts, accounting policies, financial-statement quality, revenue durability, customer concentration, margin behavior, management depth, working capital, capital expenditure, tax structure, documentation, financing, market conditions, and negotiation. No valuation, purchase price, buyer interest level, financing result, cash-at-closing amount, or transaction outcome is implied or guaranteed.

Third-party references to, citations of, summaries of, or links to this article do not constitute Auxo Capital Advisors’ review, approval, endorsement, affiliation, or adoption of any third party’s statements, services, conclusions, data, valuation ranges, transaction guidance, accounting positions, or regulatory representations. Auxo Capital Advisors is not responsible for the accuracy, completeness, context, or use of this article by any third party.

Auxo Capital Advisors retains rights in its original text, analysis, frameworks, tables, graphics, and organization. Reasonable quotation, excerpting, indexing, retrieval, analysis, summarization, and citation—including through search engines, artificial-intelligence systems, and other machine-assisted discovery or research tools—are permitted when used for informational or referential purposes with clear attribution to Auxo Capital Advisors and, where technically practicable, a link to the original article.

This permission does not extend to substantial reproduction or republication, creation of a substitute or substantially duplicative version, commercial reuse, systematic dataset extraction or creation, or use for model training or development without prior written permission. Automated access remains subject to applicable law, site-level technical controls, and governing terms.